pI: 6.6079 |
Length (AA): 511 |
MW (Da): 58005 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
7 | 511 | 4mp2 (A) | 13 | 372 | 43.00 | 0 | 1 | 0.918558 | 0.59 |
14 | 511 | 2e0a (A) | 23 | 376 | 45.00 | 0 | 1 | 0.97386 | 0.47 |
121 | 292 | 3qml (C) | 183 | 385 | 30.00 | 0.91 | 0.66 | 0.456895 | -0.18 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127409)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G06483 | pyruvate dehydrogenase kinase |
Brugia malayi | Bm1_30205 | kinase, mitochondrial precursor |
Candida albicans | CaO19.7281 | similar to S. pombe SPAC644.11c predicted pyruvate dehydrogenase kinase |
Caenorhabditis elegans | CELE_ZK370.5 | Protein PDHK-2 |
Drosophila melanogaster | Dmel_CG8808 | Pyruvate dehydrogenase kinase |
Echinococcus granulosus | EgrG_000147400 | Pyruvate dehydrogenase lipoamide kinase |
Echinococcus multilocularis | EmuJ_000147400 | Pyruvate dehydrogenase (lipoamide) kinase |
Echinococcus multilocularis | EmuJ_000136800 | Pyruvate dehydrogenase (lipoamide) kinase |
Homo sapiens | ENSG00000004799 | pyruvate dehydrogenase kinase, isozyme 4 |
Homo sapiens | ENSG00000067992 | pyruvate dehydrogenase kinase, isozyme 3 |
Homo sapiens | 5163 | pyruvate dehydrogenase kinase, isozyme 1 |
Homo sapiens | ENSG00000005882 | pyruvate dehydrogenase kinase, isozyme 2 |
Leishmania braziliensis | LbrM.20.4500 | developmentally regulated phosphoprotein-like protein |
Leishmania donovani | LdBPK_200310.1 | developmentally regulated phosphoprotein-like protein |
Leishmania infantum | LinJ.20.0310 | developmentally regulated phosphoprotein-like protein |
Leishmania major | LmjF.20.0280 | developmentally regulated phosphoprotein-like protein |
Leishmania mexicana | LmxM.20.0280 | developmentally regulated phosphoprotein-like protein |
Loa Loa (eye worm) | LOAG_02700 | hypothetical protein |
Mus musculus | ENSMUSG00000035232 | pyruvate dehydrogenase kinase, isoenzyme 3 |
Mus musculus | ENSMUSG00000019577 | pyruvate dehydrogenase kinase, isoenzyme 4 |
Mus musculus | ENSMUSG00000006494 | pyruvate dehydrogenase kinase, isoenzyme 1 |
Mus musculus | ENSMUSG00000038967 | pyruvate dehydrogenase kinase, isoenzyme 2 |
Oryza sativa | 4344039 | Os07g0637300 |
Oryza sativa | 4332932 | Os03g0370000 |
Schistosoma japonicum | Sjp_0206730 | ko:K00898 pyruvate dehydrogenase kinase [EC2.7.11.2], putative |
Schistosoma japonicum | Sjp_0215760 | [Pyruvate dehydrogenase [lipoamide]] kinase, mitochondrial precursor, putative |
Schistosoma mansoni | Smp_068170.1 | pyruvate dehydrogenase |
Schistosoma mansoni | Smp_068170.2 | pyruvate dehydrogenase |
Schistosoma mansoni | Smp_140580 | pyruvate dehydrogenase |
Schmidtea mediterranea | mk4.003066.04 | |
Schmidtea mediterranea | mk4.003066.06 | Probable |
Schmidtea mediterranea | mk4.004229.02 | |
Schmidtea mediterranea | mk4.003066.05 | |
Schmidtea mediterranea | mk4.004229.01 | |
Trypanosoma brucei gambiense | Tbg972.1.380 | developmentally regulated phosphoprotein |
Trypanosoma brucei | Tb927.1.1000 | developmentally regulated phosphoprotein |
Trypanosoma congolense | TcIL3000_1_420 | developmentally regulated phosphoprotein, putative |
Trypanosoma cruzi | TcCLB.511421.110 | developmentally regulated phosphoprotein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.1.1000 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.1.1000 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.1.1000 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.1.1000 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Rattus norvegicus | Pyruvate dehydrogenase kinase | Compounds | References |
Homo sapiens | pyruvate dehydrogenase kinase, isozyme 4 | Compounds | References |
Homo sapiens | pyruvate dehydrogenase kinase, isozyme 1 | Compounds | References |
Homo sapiens | pyruvate dehydrogenase kinase, isozyme 2 | Compounds | References |
Homo sapiens | pyruvate dehydrogenase kinase, isozyme 3 | Compounds | References |